India’s pharmaceutical sector continues its upward trajectory, with exports rising 9.4% to reach $30.47 billion in FY25. The industry is now aiming for double-digit expansion in the coming years, with projections suggesting a total valuation of $130 billion by 2030. Currently, India ranks third globally by volume, exporting life-saving medicines to over 200 markets, with the US and Europe accounting for over 50% of the total share. Recent trade engagements with the EU and the US are expected to further improve market access and price competitiveness for Indian generic drug manufacturers. The government remains committed to creating enabling conditions and resolving regulatory hurdles to sustain this export momentum.